+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Vectura Group plc - logo

Vectura Pharma was established in 1997, and its headquarters are in Chippenham in the U.K. Vectura Group plc researches, develops, and commercializes novel therapeutic products and drug delivery systems for the treatment of airways-related diseases Vectura entered into its first global commercialisation and development agreement with Novartis for NVA237. The company’s marketed products include Ultibro Breezhaler and Seebri Breezhaler for the treatment of chronic obstructive pulmonary disease (COPD).

From
Global Smart Inhaler Market 2019-2025 - Product Thumbnail Image

Global Smart Inhaler Market 2019-2025

  • Report
  • January 2020
From
Europe Inhalable Drugs Market 2020-2026 - Product Thumbnail Image

Europe Inhalable Drugs Market 2020-2026

  • Report
  • February 2020
From
From
From
From
From
From
From
Nebulizers - Medical Devices Pipeline Assessment, 2020 - Product Thumbnail Image

Nebulizers - Medical Devices Pipeline Assessment, 2020

  • Report
  • February 2020
  • 119 pages
From
From
From
Loading Indicator
adroll